Neuroscience at HIH Home
NINDS Home NIMH Home NICHD Home NIDCD Home NEI Home NIDCR Home NIA Home NIAAA Home NIDA Home NHGRI Home NIEHS Home NCI Home
National Institutes of Health - Neuroscience at HIH Link to NIH
Link to About Us
Link to Faculty
Link to Areas of Research
Link to Seminars
Link to Interest Groups
Link to Post-doctoral Openings
Link to Home
 

David S. Goldstein, M.D., Ph.D., Senior Investigator

Dr. Goldstein graduated from Yale College and received an M.D.-Ph.D. in Behavioral Sciences from Johns Hopkins. After medical internship and residency at the University of Washington, he came to the NIH as a Clinical Associate in the NHLBI, obtaining tenure as a Senior Investigator in 1984. He joined the NINDS in 1990 to head the Clinical Neurochemistry Section and founded and directs the Clinical Neurocardiology Section, an independent Section. He has received Yale's Angier Prize for Research in Psychology, the Laufberger Medal of the Czech Academy of Sciences, 2 NIH Merit Awards, the Founders Award of the Bakken Heart-Brain Institute, and the NIH Distinguished Clinical Teacher Award. He is author of more than 450 research articles and several books, including "Adrenaline and the Inner World: An Introduction to Scientific Integrative Medicine," the "NDRF Handbook for Patients with Dysautonomias," "Stress, Catecholamines, and Cardiovascular Disease," and "The Autonomic Nervous System in Health and Disease.
Photo of David S. Goldstein, M.D., Ph.D., Senior Investigator

Staff:



Research Interests:
Dr. Goldstein's main research interests are in clinical neurocardiology, catecholamine systems, and scientific integrative medicine. The Clinical Neurocardiology Section carries out mainly patient-oriented research about disorders of brain regulation of the cardiovascular system. The research emphasizes diseases of the autonomic nervous system, where the sympathetic nervous system or catecholamines play important roles, such as autonomic failure syndrome and neurogenetic conditions featuring abnormal catecholamine synthesis or metabolism. The Section operates a renowned Clinical Neurochemistry Laboratory for assays of levels of catecholamines and their metabolites. Current research of the Section focuses on biomarkers and mechanisms of Parkinson disease and related disorders that involve abnormal catecholamine systems.


Clinical Protocols:
  • Clinical Laboratory Evaluation of Primary Chronic Autonomic Failure  ( 03-N-0004 )
  • Reference Values for Plasma Catechols ( 06-N-0047 )
  • L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions with Carbidopa and Entacapone  ( 08-N-0012 )
  • Plasma Exchange for Autoimmune Autonomic Failure ( 06-N-0209 )

Selected Recent Publications:
  • Goldstein DS. (2006) Adrenaline and the Inner World: An Introduction to Scientific Integrative Medicine, Johns Hopkins University Press.

  • Goldstein DS, Eisenhofer G, Kopin IJ. (2003) Sources and significance of plasma levels of catechols and their metabolites in humans, J Pharmacol Exp Ther 305, 800-811.

  • Goldstein DS, Smith LJ (2002) The NDRF Handbook for Patients with Dysautonomias, Futura.

  • Goldstein DS (2001) The Autonomic Nervous System in Health and Disease, Taylor & Francis.

All Selected Publications


Contact Information:
Dr. David S. Goldstein
Clinical Neurocardiology Section, CNP, DIR, NINDS, NIH
Building 10, Room 6N252
10 Center Drive, MSC 1620
Bethesda, MD 20892-1620

Telephone: (301) 496-2103 (office), (301) 496-7832 (laboratory), (301) 402-0180 (fax)
Email: goldsteind@ninds.nih.gov

Please direct clinical inquiries to -
Tereza Jenkins

Telephone: (301) 496-1115 (office)
Email: jenkinst@ninds.nih.govs

top

Home   |   Email List   |   Search   |   Contact Us   |   Privacy Notice   |   Disclaimer   |   Accessibility
Comments or questions about the website?
Send email to neuroscience@nih.gov
Last updated Tuesday, January 08, 2008